Twin Capital Management’s Medtronic MDT Stock Holding History

Twin Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.02M	Sell	34,850 -171	-0.5%	-$16.4K	0.39%	68
2025 Q4	$3.36M	Sell	35,021 -285	-0.8%	-$27.7K	0.42%	58
2025 Q3	$3.36M	Buy	35,306 +10,311	+41%	+$948K	0.42%	56
2025 Q2	$2.18M	Sell	24,995 -368	-1%	-$31.2K	0.23%	115
2025 Q1	$2.28M	Sell	25,363 -461	-2%	-$41.3K	0.27%	102
2024 Q4	$2.06M	Sell	25,824 -648	-2%	-$56.1K	0.23%	117
2024 Q3	$2.38M	Sell	26,472 -1,767	-6%	-$149K	0.27%	101
2024 Q2	$2.22M	Sell	28,239 -365	-1%	-$29.9K	0.26%	105
2024 Q1	$2.49M	Buy	28,604 +9,127	+47%	+$779K	0.31%	98
2023 Q4	$1.6M	Sell	19,477 -18,158	-48%	-$1.38M	0.21%	139
2023 Q3	$2.95M	Buy	37,635 +4,643	+14%	+$389K	0.42%	60
2023 Q2	$2.91M	Buy	32,992 +11,365	+53%	+$978K	0.38%	70
2023 Q1	$1.74M	Buy	+21,627	New	+$1.76M	0.24%	129
2022 Q1	–	Sell	-27,056	Closed	-$2.8M	–	287
2021 Q4	$2.8M	Sell	27,056 -10,030	-27%	-$1.16M	0.28%	115
2021 Q3	$4.65M	Sell	37,086 -4,770	-11%	-$617K	0.48%	56
2021 Q2	$5.2M	Buy	41,856 +1,208	+3%	+$152K	0.48%	58
2021 Q1	$4.8M	Sell	40,648 -9,154	-18%	-$1.07M	0.48%	58
2020 Q4	$5.83M	Buy	49,802 +16,212	+48%	+$1.78M	0.53%	49
2020 Q3	$3.49M	Sell	33,590 -1,264	-4%	-$127K	0.32%	98
2020 Q2	$3.2M	Sell	34,854 -930	-3%	-$89.2K	0.31%	104
2020 Q1	$3.23M	Buy	35,784 +4,350	+14%	+$463K	0.35%	89
2019 Q4	$3.57M	Sell	31,434 -570	-2%	-$62.5K	0.3%	109
2019 Q3	$3.48M	Buy	32,004 +2,314	+8%	+$241K	0.25%	132
2019 Q2	$2.89M	Sell	29,690 -20,910	-41%	-$1.91M	0.2%	150
2019 Q1	$4.61M	Buy	50,600 +29,440	+139%	+$2.63M	0.23%	135
2018 Q4	$1.93M	Buy	21,160 +9,400	+80%	+$878K	0.11%	209
2018 Q3	$1.16M	Buy	+11,760	New	+$1.09M	0.05%	263
2018 Q2	–	Sell	-10,630	Closed	-$853K	–	351
2018 Q1	$853K	Hold	10,630	–	–	0.04%	288
2017 Q4	$858K	Buy	+10,630	New	+$851K	0.04%	293
2017 Q3	–	Sell	-16,370	Closed	-$1.45M	–	344
2017 Q2	$1.45M	Sell	16,370 -30	-0.2%	-$2.53K	0.09%	250
2017 Q1	$1.32M	Sell	16,400 -1,570	-9%	-$123K	0.08%	264
2016 Q4	$1.28M	Buy	17,970 +5,110	+40%	+$401K	0.08%	255
2016 Q3	$1.11M	Buy	12,860 +9,860	+329%	+$859K	0.07%	261
2016 Q2	$260K	Hold	3,000	–	–	0.02%	340
2016 Q1	$225K	Sell	3,000 -10,960	-79%	-$825K	0.02%	265
2015 Q4	$1.07M	Sell	13,960 -750	-5%	-$56.5K	0.09%	212
2015 Q3	$985K	Sell	14,710 -8,010	-35%	-$590K	0.09%	207
2015 Q2	$1.68M	Hold	22,720	–	–	0.15%	168
2015 Q1	$1.77M	Buy	22,720 +15,620	+220%	+$1.18M	0.16%	170
2014 Q4	$513K	Hold	7,100	–	–	0.05%	227
2014 Q3	$440K	Hold	7,100	–	–	0.04%	256
2014 Q2	$453K	Sell	7,100 -45,000	-86%	-$2.73M	0.05%	263
2014 Q1	$3.21M	Buy	52,100 +10,040	+24%	+$585K	0.34%	90
2013 Q4	$2.41M	Buy	42,060 +3,100	+8%	+$176K	0.26%	132
2013 Q3	$2.08M	Sell	38,960 -16,880	-30%	-$908K	0.22%	137
2013 Q2	$2.87M	Buy	+55,840	New	+$2.76M	0.31%	95

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Twin Capital Management's MDT Position: Q1 2026 in Review

Twin Capital Management reduced its Medtronic (MDT) stake by 0.49% in Q1 2026, selling an estimated $16.4K and leaving 34,850 shares worth $3.02M. The position accounts for 0.39% of the portfolio, ranked #68.

Twin Capital Management first reported a position in MDT in Q2 2013 and has held it in 46 quarters since. The position peaked at $5.83M in Q4 2020. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Twin Capital Management held 34,850 shares of Medtronic worth $3.02M as of Q1 2026.
Twin Capital Management sold 171 Medtronic shares in Q1 2026, an estimated $16.4K.
Medtronic made up 0.39% of Twin Capital Management's portfolio in Q1 2026, its #68 holding.
Twin Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 46 quarters since.
Twin Capital Management's Medtronic position peaked at $5.83M in Q4 2020.
2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Twin Capital Management's 13F filing for Q1 2026, filed 5 May 2026.